Skip to main content

#157962

Anti-sTDP43

Cat. #157962

Anti-sTDP43

Cat. #: 157962

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Shortened TAR DNA-binding protein of 43 kDa (sTDP43)

Class: Polyclonal

Application: IHC ; WB

Host: Rabbit

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Sami Barmada

Institute: University of Michigan

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-sTDP43
  • Research fields: Neurobiology
  • Tool sub type: Primary antibody
  • Class: Polyclonal
  • Purpose: Marker
  • Conjugation: Unconjugated
  • Host: Rabbit
  • Application: IHC ; WB
  • Description: This polyclonal antibody recognizes the shortened isoform of the TDP43 protein that is involved in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.
  • Immunogen: EGFP fused to the 18-amino acid C-terminus of sTDP43
  • Immunogen uniprot id: TADBP_HUMAN

Target Details

  • Target: Shortened TAR DNA-binding protein of 43 kDa (sTDP43)
  • Tissue cell line specificity: Rabbit
  • Target background: This polyclonal antibody recognizes the shortened isoform of the TDP43 protein that is involved in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.

Applications

  • Application: IHC ; WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Weskamp et al. 2020. J Clin Invest. 130(3):1139-1155. PMID: 31714900.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.